Paraneoplastic syndrome not seen in renal cell cancer is?
The question is asking which one is NOT seen. Let's think about the options. The options aren't listed, but the correct answer is supposed to be a syndrome that's not typically linked to RCC. For example, Cushing's syndrome is more associated with adrenal tumors or ectopic ACTH production, but not typically with RCC. On the other hand, hypoglycemia can occur in RCC due to tumor production of insulin-like growth factors.
Wait, but some sources mention that RCC can cause Cushing's syndrome if it's producing ACTH. Is that rare? Maybe the question is testing the more common paraneoplastic syndromes. Alternatively, maybe a syndrome like SIADH is not associated with RCC. Let me verify. SIADH is more common in SCLC or small cell lung cancer. So if one of the options is SIADH, that would be the correct answer here.
So the core concept is paraneoplastic syndromes of RCC. The correct answer would be a syndrome not typically linked. Let's structure the explanation accordingly. The Core Concept would mention that RCC can cause various paraneoplastic effects due to ectopic hormone production. The correct answer explanation would detail why the chosen syndrome isn't associated. Each wrong option's flaw would be explained. The clinical pearl would highlight the common syndromes to remember.
**Core Concept**
Paraneoplastic syndromes in renal cell carcinoma (RCC) arise from ectopic hormone production or immune-mediated mechanisms. **Common manifestations** include erythrocytosis, hypercalcemia, and hyperviscosity, driven by tumor-secreted cytokines like erythropoietin or PTH-related protein.
**Why the Correct Answer is Right**
**Option C:** Cushing’s syndrome is **not** a paraneoplastic syndrome of RCC. It typically results from ectopic ACTH secretion (e.g., small cell lung cancer) or adrenal tumors. RCC rarely produces ACTH, making this condition clinically irrelevant in the context of renal malignancy.
**Why Each Wrong Option is Incorrect**
**Option A:** Erythrocytosis (secondary to erythropoietin overproduction) is a classic feature of RCC.
**Option B:** Hypercalcemia occurs due to PTH-related protein secretion by the tumor.
**Option D:** Hyperviscosity syndrome from monoclonal IgG is a known paraneoplastic effect in RCC.
**Clinical Pearl / High-Yield Fact**
Remember the **"3 Hs"** for RCC paraneoplastic syndromes: **Hypercalcemia** (PTHrP), **Hyperviscosity** (IgG), and **Hemorrhagic diathesis** (coagulation factor interference). Cushing’s syndrome is not part of this triad